MedTrace Logo

Safety,Effectiveness and Acceptability of Sino-implant II in DR

NCT01594632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2017-09-21

No results posted yet for this study

Summary

A study to assess the contraceptive effectiveness of Sino-implant (II).

Conditions

  • Contraception

Interventions

DRUG

Jadelle

LNG containing subdermal contraceptive implant

DRUG

Sino-implant (II)

LNG containing subdermal contraceptive implant

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • FHI 360

    lead OTHER

Principal Investigators

  • Vivian Brache, LIC · Profamilia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2017-07-04
Completion
2017-07-04

Countries

  • Dominican Republic

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594632 on ClinicalTrials.gov